SecSonar.com

OmniAb, Inc. (OABI)

OmniAb, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

OmniAb, Inc. (OABI) is a Biotechnology company based in US with a market capitalization of $323.4M. Revenue declined 29.3% year-over-year and free cash flow was negative at -$37M. This page tracks OABI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 114 employees · IPO Sep 30, 2021

Valuation

Valuation & price

$2.18 · as of May 17, 2026 · -19.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.21

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.72$2.05$1.38Jul 25Dec 25Jul 26Jul 7, 25$1.87Jul 9, 25$2.20Jul 11, 25$2.03Jul 15, 25$1.95Jul 17, 25$1.96Jul 21, 25$1.98Jul 23, 25$2.15Jul 25, 25$2.10Jul 29, 25$1.96Jul 31, 25$1.91Aug 4, 25$1.95Aug 6, 25$1.93Aug 11, 25$1.96Aug 13, 25$2.05Aug 15, 25$2.01Aug 19, 25$2.02Aug 21, 25$1.80Aug 25, 25$1.63Aug 27, 25$1.61Aug 29, 25$1.60Sep 3, 25$1.52Sep 5, 25$1.71Sep 9, 25$1.57Sep 11, 25$1.60Sep 16, 25$1.61Sep 18, 25$1.66Sep 22, 25$1.70Sep 24, 25$1.58Sep 26, 25$1.61Sep 30, 25$1.60Oct 2, 25$1.61Oct 6, 25$1.68Oct 8, 25$1.75Oct 10, 25$1.62Oct 14, 25$1.61Oct 16, 25$1.70Oct 21, 25$1.66Oct 23, 25$1.60Oct 27, 25$1.59Oct 29, 25$1.47Oct 31, 25$1.55Nov 4, 25$1.48Nov 6, 25$1.38Nov 10, 25$1.49Nov 12, 25$1.57Nov 14, 25$1.56Nov 18, 25$1.61Nov 20, 25$1.67Nov 25, 25$1.86Nov 28, 25$1.81Dec 2, 25$1.71Dec 4, 25$1.97Dec 8, 25$1.99Dec 10, 25$2.00Dec 12, 25$2.15Dec 16, 25$2.05Dec 18, 25$2.01Dec 22, 25$2.05Dec 24, 25$1.96Dec 29, 25$1.90Jan 2, 26$1.88Jan 6, 26$1.84Jan 8, 26$1.89Jan 12, 26$1.91Jan 14, 26$1.91Jan 16, 26$1.90Jan 21, 26$2.01Jan 23, 26$1.96Jan 27, 26$1.96Jan 29, 26$1.86Feb 2, 26$1.79Feb 4, 26$1.74Feb 9, 26$1.79Feb 11, 26$1.70Feb 13, 26$1.70Feb 18, 26$1.71Feb 20, 26$1.70Feb 24, 26$1.73Feb 26, 26$1.80Mar 2, 26$1.76Mar 4, 26$1.81Mar 6, 26$1.89Mar 10, 26$1.99Mar 12, 26$1.85Mar 17, 26$1.83Mar 19, 26$1.84Mar 23, 26$1.76Mar 25, 26$1.62Mar 27, 26$1.51Mar 31, 26$1.57Apr 2, 26$1.54Apr 7, 26$1.51Apr 9, 26$1.50Apr 13, 26$1.46Apr 15, 26$1.48Apr 17, 26$1.64Apr 22, 26$1.50Apr 24, 26$1.46Apr 28, 26$1.40Apr 30, 26$1.39May 4, 26$1.41May 6, 26$1.43May 8, 26$1.66May 12, 26$1.85May 14, 26$2.19May 18, 26$2.29May 20, 26$2.58May 22, 26$2.65May 28, 26$2.72Jun 1, 26$2.61Jun 3, 26$2.50Jun 5, 26$2.48Jun 9, 26$2.40Jun 11, 26$2.34Jun 15, 26$2.11Jun 17, 26$2.03Jun 22, 26$2.32Jun 24, 26$2.28Jun 26, 26$2.52Jul 2, 26$2.42
$1.3652-week range$2.72
Loading valuation history…

Fundamentals

Key fundamentals

$323.4M

Market cap

-29.3%

Revenue growth (YoY)

-18.2%

Gross margin

-$37M

Free cash flow (USD)

-$33.7M

Net debt

Net cash position

11.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$18.3MFY 2020$23.3MFY 2021$34.7MFY 2022$59.1MFY 2023$34.2MFY 2024$26.4MFY 2025$18.7M
$18.3M$18.7M

Free cash flow by year

2019 → 2025

FY 2019$-5.5MFY 2020$1.9MFY 2021$-9.7MFY 2022$-20.8MFY 2023$703.0KFY 2024$-41.5MFY 2025$-37.0M
-$5.5M-$37M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025-18.2%
100.0%-18.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is OmniAb, Inc.'s market cap?

OmniAb, Inc. (OABI) has a market capitalization of $323.4M.

What is OABI's P/E ratio?

A meaningful P/E ratio is not available for OABI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is OABI's price-to-book (P/B) ratio?

OABI trades at 1.21 times book value per share.

Are insiders buying OABI stock?

SEC Form 4 filings show no open-market insider buys at OmniAb, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

EVMN

Evommune, Inc.

$324.9M

BCYC

Bicycle Therapeutics plc

$325.5M

SLN

Silence Therapeutics plc

$320.4M

FATE

Fate Therapeutics, Inc.

$317M

EDIT

Editas Medicine, Inc.

$331.4M

CMPX

Compass Therapeutics, Inc.

$334M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.